Aldevron and Integrated DNA Technologies have announced a license agreement in which Aldevron will manufacture and distribute a S. pyogenes Cas9 variant (SpyFiTM Cas9 Nuclease), which is patented by IDT. The product will be manufactured for research, clinical, and commercial use.     “IDT continues to be an innovator for the biotechnology industry. We are excited to expand our partnership,” said Michael Chambers, Aldevron’s chief executive officer. “This license will accelerate gen...